Cochlear Limited
CHEOY · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Revenue | $2,343 | $2,236 | $1,956 | $1,641 |
| % Growth | 4.8% | 14.3% | 19.2% | – |
| Cost of Goods Sold | $615 | $562 | $488 | $411 |
| Gross Profit | $1,728 | $1,674 | $1,468 | $1,230 |
| % Margin | 73.7% | 74.9% | 75% | 75% |
| R&D Expenses | $292 | $277 | $245 | $211 |
| G&A Expenses | $208 | $213 | $204 | $159 |
| SG&A Expenses | $940 | $898 | $810 | $658 |
| Sales & Mktg Exp. | $732 | $685 | $607 | $499 |
| Other Operating Expenses | $90 | $85 | -$3 | $0 |
| Operating Expenses | $1,322 | $1,260 | $1,055 | $868 |
| Operating Income | $406 | $475 | $412 | $362 |
| % Margin | 17.3% | 21.2% | 21.1% | 22% |
| Other Income/Exp. Net | $112 | $10 | -$16 | -$6 |
| Pre-Tax Income | $519 | $485 | $397 | $394 |
| Tax Expense | $130 | $128 | $96 | $105 |
| Net Income | $389 | $357 | $301 | $289 |
| % Margin | 16.6% | 16% | 15.4% | 17.6% |
| EPS | 2.97 | 2.72 | 2.29 | 2.2 |
| % Growth | 9.2% | 18.8% | 4.1% | – |
| EPS Diluted | 2.97 | 2.72 | 2.28 | 2.2 |
| Weighted Avg Shares Out | 131 | 131 | 132 | 132 |
| Weighted Avg Shares Out Dil | 131 | 131 | 132 | 132 |
| Supplemental Information | – | – | – | – |
| Interest Income | $12 | $19 | $17 | $2 |
| Interest Expense | $11 | $9 | $9 | $9 |
| Depreciation & Amortization | $90 | $85 | $81 | $73 |
| EBITDA | $620 | $579 | $487 | $435 |
| % Margin | 26.5% | 25.9% | 24.9% | 26.5% |